These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11281395)

  • 1. Porphyria cutanea tarda in a patient with post-transplant MDS.
    Oubre D; Cruz J; Keung Y
    Bone Marrow Transplant; 2001 Jan; 27(2):219-20. PubMed ID: 11281395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary acute myeloid leukemia and myelodysplasia after autologous peripheral blood progenitor cell transplantation.
    Sevilla J; Rodríguez A; Hernández-Maraver D; de Bustos G; Aguado J; Ojeda E; Arrieta R; Hernández-Navarro F
    Ann Hematol; 2002 Jan; 81(1):11-5. PubMed ID: 11807629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porphyria cutanea tarda, dermatomyositis and non-Hodgkin lymphoma in virus C infection.
    Bauzá A; España A; Lloret P
    Eur J Dermatol; 2003; 13(3):302-4. PubMed ID: 12804996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
    Friedberg JW
    Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of treatment-related myelodysplastic syndrome and acute myelogenous leukemia following high-dose chemotherapy with autologous stem cell transplantation for non-Hodgkin's lymphoma.
    Jang GD; Kim SW; Suh CW; Kim EK; Bahng HS; Jeong YH; Park IG; Kim WK; Kim SH; Suh EJ; Park CJ; Ji HS; Lee JS
    J Korean Med Sci; 2002 Aug; 17(4):555-9. PubMed ID: 12172056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periodic morphologic, cytogenetic and clonality evaluation after autologous peripheral blood progenitor cell transplantation in patients with lymphoproliferative malignancies.
    Laurenti L; Chiusolo P; Garzia MG; Zini G; Sorà F; Piccirillo N; Piccioni P; Zollino M; Leone G; Sica S
    Haematologica; 2002 Jan; 87(1):59-66. PubMed ID: 11801466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors before autologous stem-cell transplantation for lymphoma predict for secondary myelodysplasia and acute myelogenous leukemia.
    Kalaycio M; Rybicki L; Pohlman B; Sobecks R; Andresen S; Kuczkowski E; Bolwell B
    J Clin Oncol; 2006 Aug; 24(22):3604-10. PubMed ID: 16877727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of conventional therapy alone versus conventional therapy followed by autologous hematopoietic stem-cell transplantation.
    Forrest DL; Hogge DE; Nevill TJ; Nantel SH; Barnett MJ; Shepherd JD; Sutherland HJ; Toze CL; Smith CA; Lavoie JC; Song KW; Voss NJ; Gascoyne RD; Connors JM
    J Clin Oncol; 2005 Nov; 23(31):7994-8002. PubMed ID: 16204014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K; Fukuda T; Makino S; Harada M
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.
    Josting A; Wiedenmann S; Franklin J; May M; Sieber M; Wolf J; Engert A; Diehl V;
    J Clin Oncol; 2003 Sep; 21(18):3440-6. PubMed ID: 12668650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphoma.
    Laudi N; Arora M; Burns LJ; Miller JS; McGlave PB; Barker JN; Ramsay NK; Orchard PJ; Macmillan ML; Weisdorf DJ
    Biol Blood Marrow Transplant; 2005 Feb; 11(2):129-35. PubMed ID: 15682074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hepatitis B after autologous stem cell transplantation in a man previously infected by hepatitis B virus.
    Senecal D; Pichon E; Dubois F; Delain M; Linassier C; Colombat P
    Bone Marrow Transplant; 1999 Dec; 24(11):1243-4. PubMed ID: 10642815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyria cutanea tarda associated with lymphoma.
    Maughan WZ; Muller SA; Perry HO
    Acta Derm Venereol; 1979; 59(1):55-8. PubMed ID: 84468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful long-term control with lamivudine against reactivated hepatitis B infection following intensive chemotherapy and autologous peripheral blood stem cell transplantation in non-Hodgkin's lymphoma: experience of 2 cases.
    Nakagawa M; Simizu Y; Suemura M; Sato B
    Am J Hematol; 2002 May; 70(1):60-3. PubMed ID: 11994984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in a Patient with Concomitant Porphyria Cutanea Tarda.
    Mohamed ZA; Pelletier S; Vintze-Geoffrion A; Lagacé-Nadon S; Olney HJ; Adam JP
    Clin Lymphoma Myeloma Leuk; 2021 Mar; 21(3):e264-e266. PubMed ID: 33390349
    [No Abstract]   [Full Text] [Related]  

  • 18. Vanishing bile duct syndrome occurring after high-dose chemotherapy and autologous peripheral stem cell transplantation in a patient with Hodgkin's disease.
    Kömürcü S; Ozet A; Altundag MK; Arpaci F; Oztürk B; Celasun B; Tezcan Y
    Ann Hematol; 2002 Jan; 81(1):57-8. PubMed ID: 11807639
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma.
    Stone RM; Neuberg D; Soiffer R; Takvorian T; Whelan M; Rabinowe SN; Aster JC; Leavitt P; Mauch P; Freedman AS
    J Clin Oncol; 1994 Dec; 12(12):2535-42. PubMed ID: 7989927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic stem cell transplant in first remission in non-Hodgkin's lymphoma.
    Tomblyn M; Winter JN
    Expert Rev Anticancer Ther; 2003 Jun; 3(3):281-94. PubMed ID: 12820773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.